Home » Topics » Briefs » Other news to note

Other news to note
RSS

Other news to note for Nov. 4, 2019

Nov. 4, 2019

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Nov. 4, 2019

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Nov. 1, 2019

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Nov. 1, 2019

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Oct. 31, 2019

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Oct. 31, 2019

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Oct. 30, 2019

Oct. 30, 2019

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Oct. 30, 2019

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Oct. 30, 2019

Mergers and acquisitions in the med-tech industry.

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...